/

Other

/

Vividion Therapeutics, Inc.

Vividion Therapeutics, Inc.

Vividion Therapeutics, Inc.

Verified Nov 2026

Other

·

United States flag

San Diego, California

·

Since 2017

Vividion Therapeutics is a clinical-stage biopharmaceutical company founded in 2017 and headquartered in San Diego, California. With 200–500 employees and estimated revenue of $50–100 million, it operates as a wholly owned subsidiary of Bayer AG following acquisition in August 2021. The company develops precision small-molecule therapeutics targeting cancers and immune disorders using its proprietary chemoproteomic platform to identify previously inaccessible protein binding sites.

Vividion Therapeutics, Inc.

Verified Nov 2026

AT A GLANCE

Founded

2017

Headquarters

United States flag

San Diego, California

Employees

200-500

Ownership

Vividion Therapeutics, Inc. at a glance

Revenue

$50-100M

Est. band

Employees

200-500

Founded

2017

Headquarters

San Diego, California

Industries

Automotive

Electric Vehicles

Medical

Overview

Vividion Therapeutics is a clinical-stage biopharmaceutical company founded in 2017 and headquartered in San Diego, California. With 200–500 employees and estimated revenue of $50–100 million, it operates as a wholly owned subsidiary of Bayer AG following acquisition in August 2021. The company develops precision small-molecule therapeutics targeting cancers and immune disorders using its proprietary chemoproteomic platform to identify previously inaccessible protein binding sites.

At a glance

Attribute

Detail

Founded

2017

Headquarters

San Diego, California

Employees

200-500

Revenue

$50-100M (estimated)

What Vividion Therapeutics, Inc. makes

The company operates a drug discovery platform integrating chemoproteomics, synthetic chemistry, and proteome-wide target discovery to create first-in-class therapeutics aimed at undruggable proteins in oncology and immunology.

Latest developments

Facilities

Vividion Therapeutics, Inc. is headquartered in San Diego, California. Public sources also reference these locations:

Company details

Vividion is a subsidiary of Bayer AG and maintains a diverse pipeline of candidates focused on precision therapeutics that minimize off-target effects in oncology and autoimmune disease. Vividion Therapeutics, Inc. was founded in 2017, has an estimated 200-500 employees, and is headquartered in San Diego, California.

Frequently asked questions

What does Vividion Therapeutics, Inc. do?

Vividion Therapeutics is a clinical-stage biopharmaceutical company founded in 2017 and headquartered in San Diego, California. With 200–500 employees and estimated revenue of $50–100 million, it operates as a wholly owned subsidiary of Bayer AG following acquisition in August 2021. The company develops precision small-molecule therapeutics targeting cancers and immune disorders using its proprietary chemoproteomic platform to identify previously inaccessible protein binding sites.

Where is Vividion Therapeutics, Inc. headquartered?

Vividion Therapeutics, Inc. is headquartered in San Diego, California (5820 Nancy Ridge Drive, San Diego, California, 92121).

When was Vividion Therapeutics, Inc. founded?

Vividion Therapeutics, Inc. was founded in 2017.

How big is Vividion Therapeutics, Inc.?

Vividion Therapeutics, Inc. has an estimated 200-500 employees, with revenue in the $50-100M range (estimated).

Related suppliers

Explore other suppliers in the LightSource directory:

Last verified Nov 2026. Is this your company? Request a correction.

Location & contact

San Diego, California (HQ)Headquarters · United States
San Diego, California (HQ)5820 Nancy Ridge Drive, San Diego, California, 92121, United StatesHeadquarters

Evaluating suppliers like these?

This profile is part of a public-data sample of the full LightSource directory. Book a demo to see the full LightSource marketplace and supplier discovery platform — 1M+ credible suppliers, with AI-run sourcing events.